TORONTO — The lack of clinical trials testing the efficacy of treatments for axial disease in juvenile spondyloarthritis (axJSpA) remains a large unmet need, according to experts. Now, the first-ever, ...
TORONTO — After almost 10 years, the much-anticipated revision of the current classification criteria for axial spondyloarthritis (axSpA) is ready for prime time. An abstract of the modified criteria ...
A panel of experts and researchers have developed a new classification system for gout, the most common form of inflammatory arthritis. This new system standardizes the classification of this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results